BlueCrest Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,571	Closed	-$269K	–	574
2019 Q1	$269K	Buy	+11,571	New	+$269K	0.01%	759
2018 Q4	–	Sell	-14,900	Closed	-$324K	–	987
2018 Q3	$324K	Buy	+14,900	New	+$324K	0.01%	979